AI Clinical Assistant Heidi Hits $900m Valuation, Here's What That Means for Your GP and the NHS in Scotland

Melbourne-based Heidi has raised $340m at a $900m valuation to expand its AI clinical assistant, which cuts the time doctors spend writing notes and managing admin. The scale of the funding is a signal, not just a headline. AI is moving into healthcare at pace, and Scottish GP practices and NHS boards need to be paying attention.

Heidi, the AI-powered clinical assistant co-founded by Dr Thomas Kelly, has closed $340m in new funding across two tranches: a $100m Series C led by Blackbird, followed by a $240m raise that doubled the company's valuation to $900m. That is a significant bet, and it is not coming from people who back hunches. It is coming from investors who have looked hard at the problem of clinical admin and decided it is one of the most solvable, and most valuable, problems in modern medicine.

The core product is straightforward in concept, transformative in practice. Heidi listens to a clinical consultation, processes the conversation, and produces structured clinical notes, referral letters, and follow-up summaries without the doctor lifting a finger after the appointment. Dr Kelly has been clear that the ambition always ran beyond note-taking. The company is positioning itself as a comprehensive clinical operating layer, the AI backbone that sits beneath a doctor's working day.

This matters directly to Scotland. According to the British Medical Association Scotland, GP practices are under sustained pressure, with administrative burden consistently cited as a primary driver of burnout and reduced patient-facing time. A 2023 report from the Royal College of General Practitioners found that GPs spend, on average, two hours on admin for every hour they spend with patients. Tools like Heidi attack that ratio directly, not by replacing clinicians but by absorbing the repetitive, low-value documentation work that currently steals clinical hours.

The Scottish Government's digital health strategy, set out in its Scotland's Digital Health and Care Strategy, explicitly names AI-assisted tools as a priority for NHS efficiency gains. NHS Scotland's National Services Division has been running pilots of ambient clinical intelligence tools, though adoption across general practice remains uneven. The Heidi funding round, and the broader $900m market signal it sends, is likely to accelerate procurement conversations that have, until now, moved slowly. When a category of software reaches near-unicorn status, health boards start writing proper business cases.

For Scottish healthcare professionals reading this, the practical question is not whether AI clinical assistants are coming. They are here. The question is whether your practice or board gets ahead of it on your own terms, piloting tools like Heidi, Suki, or Nabla in a controlled way, or whether you end up with a top-down rollout decided three levels above you. According to research published in the Lancet Digital Health in 2024, clinician-led adoption of AI tools produces significantly better outcomes and higher sustained usage than institution-led mandates. The window for leading, rather than being led, is still open.

What this means for you: If you work in or alongside Scottish healthcare, this is the moment to get familiar with AI clinical assistant tools, not to wait for NHS Scotland to mandate one. Heidi, Suki, and Nabla all offer trial access. Book a demo, run it for a fortnight, and form a view before someone else forms it for you. The same principle applies if you run a health-adjacent SME: AI admin tools are no longer experimental, and the ROI case is being written in billion-dollar funding rounds.